XDR-TB transmission in London: Case management and contact tracing investigation assisted by early whole genome sequencing

J Infect. 2016 Sep;73(3):210-8. doi: 10.1016/j.jinf.2016.04.037. Epub 2016 Jun 14.

Abstract

Objectives: We describe the first published cluster of extensively drug resistant Tuberculosis (XDR-TB) in the UK and show how early whole genome sequencing (WGS) of Mtb can assist in case management and contact investigations.

Methods: We describe the contact tracing investigation undertaken after the presentation of an adult with XDR-TB. Active cases were treated with an XDR-TB drug regimen and contacts underwent a programme of follow-up for 2 years. All isolates of Mycobacterium tuberculosis (Mtb) were assessed early using whole genome sequencing (WGS) as well as routine drug susceptibility testing (DST).

Results: Thirty-three contacts were screened. In the first year one confirmed and one probable case were identified through contact tracing. A further possible case was identified through epidemiological links. Two confirmed cases were identified through WGS 2 years later. Twenty-five (80%) contacts without evidence of tuberculosis were adherent to 1 year of follow-up and 14 (45%) were adherent to 2 years of follow-up. WGS of Mtb was used to guide drug choices, rapidly identify transmission events, and alter public health management.

Conclusion: WGS of Mtb enabled rapid effective individualized treatment and facilitated public health interventions by early identification of transmission events.

Keywords: Contact tracing; Disease outbreaks; Drug resistance; Pathology, molecular; Tuberculosis.

MeSH terms

  • Adult
  • Antitubercular Agents / therapeutic use
  • Case Management*
  • Child
  • Contact Tracing*
  • Disease Outbreaks
  • Extensively Drug-Resistant Tuberculosis / drug therapy
  • Extensively Drug-Resistant Tuberculosis / epidemiology*
  • Extensively Drug-Resistant Tuberculosis / prevention & control
  • Extensively Drug-Resistant Tuberculosis / transmission*
  • Female
  • Genome, Bacterial*
  • Humans
  • London / epidemiology
  • Male
  • Middle Aged
  • Mycobacterium tuberculosis / drug effects
  • Mycobacterium tuberculosis / genetics*
  • Mycobacterium tuberculosis / isolation & purification
  • Sequence Analysis, DNA

Substances

  • Antitubercular Agents